title: Comparison of terbinafine and clotrimazole in treating tinea pedis.
abstract: OBJECTIVE
  To compare the efficacy and safety of terbinafine 1% cream and clotrimazole 1% cream in the treatment of tinea pedis.
  
  
  METHODS
  Multicentre, double blind parallel group study.
  
  
  METHODS
  32 general practices and one hospital.
  
  
  METHODS
  256 patients with mycologically confirmed tinea pedis. Of the 211 patients evaluable, 107 were randomised to terbinafine (75 male, 32 female; mean (range) age 40 (12-81) years) and 104 to clotrimazole (79 male, 25 female; mean (range) age 36 (12-71) years).
  
  
  METHODS
  Terbinafine 1% cream applied twice daily for one week and inert cream applied twice daily for the next three weeks. Clotrimazole 1% cream applied twice daily for four weeks.
  
  
  METHODS
  Mycological cure (negative results on microscopy and culture) and effective treatment (mycological cure plus no or minimal signs and symptoms) measured at weeks 1, 2, 3, 4, and 6.
  
  
  RESULTS
  At week four rates of mycological cure were 93.5% for terbinafine and 73.1% for clotrimazole (p = 0.0001); and at week six 97.2% for terbinafine and 83.7% for clotrimazole (p = 0.001). Rates of effective treatment at week 4 were 89.7% for terbinafine and 58.7% for clotrimazole (p = 0.0001); and 89.7% for terbinafine and 73.1% for clotrimazole (p = 0.002) at week 6.
  
  
  CONCLUSIONS
  These results indicate that a one week course of terbinafine 1% cream is more effective in the treatment of tinea pedis than a four week course of clotrimazole 1% cream, both in terms of mycological cure and effective treatment.
authors.affiliation: Department of Microbiology, University of Leeds and General Infirmary.
authors.forename: E G
authors.initials: EG
authors.lastname: Evans
authors.forename: B
authors.initials: B
authors.lastname: Dodman
authors.forename: D M
authors.initials: DM
authors.lastname: Williamson
authors.forename: G J
authors.initials: GJ
authors.lastname: Brown
authors.forename: R G
authors.initials: RG
authors.lastname: Bowen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000627:therapeutic use*; D002648:Child; D003022:Clotrimazole / Q000627:therapeutic use*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004821:Epidermophyton / Q000302:isolation & purification; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use*; D000077291:Terbinafine; D014008:Tinea Pedis / Q000188:drug therapy* / Q000382:microbiology; D016896:Treatment Outcome; D014249:Trichophyton / Q000302:isolation & purification
chemical_list: D000935:Antifungal Agents; D009281:Naphthalenes; D003022:Clotrimazole; D000077291:Terbinafine